Corporate Compliance & Transparency

Similar documents
Method of Declaration. Hospitality/Interest/Sponsorship

Life Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)

PHARMA LAWCONVENTION

Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium

Early Valuation. Company Portfolio

2017 IPCC Attendee List

Workshop on. Evolving the Regulatory Review Process What are the features which enable a transparent, timely, predictable and good quality review?

Previous Attendees List:

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

CONFERENCE AGENDA. Empowering Your Clinical Trial Operations Through Digital Innovation. 5 6 December 2018, Grand Copthorne Waterfront, Singapore

IPCAA. Regulatory awareness still needs improving. INTERNATIONAL PHARMACEUTICAL CONGRESS ADVISORY ASSOCIATION No. 35 July 2010

2018 IPCC Attendee List

24-25 January 2013 PROGRAMME. Intercontinental Financial Street, Beijing, P.R. China

Innovation and the Changing Practice of Medicine

2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions

B20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems

POST EVENT REPORT IP Life Sciences Exchange 2015

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

Connecting People, Science and Regulation

SZF Associates. SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry.

Ownership/ Partnership/ Principal. None None None Lantheus Medical Imaging (DSMB) NIH (DSMB)* None None None None None None

(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K

Berlin Summit, Hotel Adlon Kempinski, April 26-27, 2012

Annual Benefit-Risk Workshop

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

Plasma Chemistry and Plasma Processing November 13-14, 2017 Vienna, Austria

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

BIOPHARMACEUTICAL SECTOR TRAINING SESSION (DAY ONE) 1 SEPTEMBER 2014

Invitation ANNUAL ASSEMBLY 2018

Working together to achieve shared goals in product packaging and labelling

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

We Work For Health Champions Awards Class of AstraZeneca: John McCarthy Vice President, Commercial Operations

The London Investor Show

The Evolution of Policy 0070: EMA Clinical Data Publication

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

Women in Leadership Roadshow 2019

The 2011 EU industrial R&D investment SCOREBOARD

BREAKTHROUGH CONVENTION SUMMARY JUNE SAN DIEGO CONVENTION.BIO.ORG #BIO2017

[Definitions of terms that are underlined are found at the end of this document.]

TODAY LETTER DATED

LISA TILTON-McCARTHY

TRENDS IN IP DISPUTES

VALUE BASED HEALTHCARE. 20 th SEPTEMBER 2018 KINGDOM OF SAUDI ARABIA Venue : Riyadh Marriott Hotel, Riyadh, KSA

EXPO. October 15-17, 2014 ADVANCE PROGRAM HEALTHCARE SUPPLY CHAIN. Register online at. JW Marriott Washington, DC

Koen Dejonckheere. Professional experience. Board Memberships. Education

Mastering Environmental Monitoring

Biotech Concerto #6 Investment Process December 2008

Please join us as a committed sponsor to make the NC CEO Forum as spectacular, educational and enjoyable as ever. We can t do this without you!

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Dammika Peiris, Senior Pharmacovigilance Manager and Head of Chugai Pharma Europe

The Assessment of Benefits and Harms and Their Relative Importance for Patients, Industry and Agencies: How should they be captured?

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.

Women leaders transforming the future through gender partnership

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

European Forum for Qualified Person for Pharmacovigilance (QPPV)

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

European companies outpace American counterparts in R&D investment growth for the first time in five years

Analytical and Bioanalytical Methods

Patent Documentation Group

International Strategy Development Training: a personal strategic development workshop for Life Sciences Executives of SMEs

May 13, 2015 London Life Sciences College Cristina Menendez Ruiz

Life Sciences Regulatory

Welcome and Opening Remarks. Orion A,B & C 9:35 10:00 Keynote Speaker

American Chamber of Commerce in Taipei

2019 EBA WESTERN CHAPTER ANNUAL MEETING

AGM & Conference. 25 th January Marketing Pack

NVESTOR. 1,400+ Attendees. 2,700+ Partnering Meetings. 768 Companies. 700 Registered Investors. 158 Company Presentations

SPONSORING PACKAGE 3D Medical Printing Conference &Expo. Perugia, Italy 7nd edition July 9 &

International Conference on PharmScience Research & Development. March 04-06, Welcome to the City of Lights. Venue

12th Annual Development Finance Institutions (DFI) Corporate Governance Conference

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Building quality into HTA and Coverage Decision- Making Processes: What are the features of good practice in HTA?

This report is prepared by:

RISK MANAGEMENT AND PHARMACOVIGILANCE SUMMIT SEPTEMBER 2017 I VIENNA

FACILITIES OF THE FUTURE. Innovating the Future of Manufacturing FEBRUARY REGISTER NOW!

Country Organisation. CADTH; DSEN, Canadian Institutes of Health Research, INESSS, Alberta Health Services. Danish Health and Medicines Authority

GMPs FOR CURRENT TIMES

INREV Conference Berlin. Programme

Advanced Biomedical Engineering and Instrumentation Summit

Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through

Global Events. Solar Storage Finance Future Grids

20-21 May 2012 Rocco Forte Hotel Abu Dhabi/UAE Conference & Health IT Leadership Summit. Postshow

LIGAND PHARMACEUTICALS INCORPORATED (Exact Name of Registrant as Specified in Its Charter)

The rise of Corporate Venture Capital investment in UK biotech

FUTURE OIL & GAS 12th - 13th JUNE 2018, Robert Gordon University, ABERDEEN, UK

PROPERTY ACCOUNTING BREAKOUT Draft Agenda

European Patent Reform Forum USA December , New York

The 2010 EU industrial R&D investment SCOREBOARD

FROM VOLUME TO VALUE THE USE OF REAL WORD EVIDENCE TO IMPROVE CLINICAL PROGRAMS AND PATIENTS LIVES

REDEFINING THE PHARMA HCP CUSTOMERS RELATIONSHIPS

WINNING PORTFOLIO CAREERS 2018

MEMBER COMPANIES AND PARTICIPATING AUTHORITIES

INREV Conference Berlin. Programme

10:00 Reducing Complexity in Pharma Marc Philipp & Markus Hayek, Accenture. Session 1 Regulatory Updates Moderator: Jette Christensen, Novo Nordisk

Workshop. Enhancing Innovation: Collaborative Mechanisms For Intellectual Property Management in the Life Sciences

Aligning global value-based decision making THE CIRS 2018 AGENDA CONSENSUS TRUST ACCESS

a Part of BioTaiwan 2015 Events July 22-23, F, Bldg. A, CTBC Financial Park Organized by Taiwan Bio Industry Organization

Transcription:

4 th Annual Conference Corporate Compliance & Transparency in the Pharmaceutical Industry 24 25 February 2016 Zürich, Switzerland

Conference In Numbers 84 Attendees 2 Days 29 Speakers 19 Participating Countries 17 Program Hours 8 Hours of Networking Top Speakers Christophe Lesguer Vice President, Chief Compliance Officer Europe Mylan Nina Stoeckel Director, Head of Group Compliance Programs Merck KGaA Marcela Kirberger Global Compliance Officer Sandoz International GmbH Michiel Lodewijks Compliance Officer Roche Michaeline Daboul President/CEO MediSpend Xavier Cimino Managing Director Accenture Dominique Oliver Ahnsehl Compliance Counsel Bayer HealthCare Milada Brabcova Compliance Director Eli Lilly Paul Melling Partner Baker & McKenzie Neli Nedkova Head of Compliance & Ethics Central and Eastern Europe Boehringer-Ingelheim Montserrat Alvarez Global Head Xpend Transparency Novartis Detlef Geiges Compliance Assurance Lead EMEA AstraZeneca Richard Walters Head of Ethics & Compliance, Pharma Europe GlaxoSmithKline Meltem Ozker Gunduz Legal Affairs & Compliance Director, Business Area Near East (BANE) Novo Nordisk Karl Boonen Senior Director, Business Practices and Compliance EMEA & Canada Johnson & Johnson Top Presentations On-stage interview with EFPIA Update on Implementation of Disclosure Code Best-rated session Local Perspective: Disclosure and Transparency Lessons Learned by Novo Nordisk A Speak-Up, Compliance Culture by Mylan Transparency Obligations Examples of Implementation and First Outcomes by Bayer Healthcare Best practices: Compliance Program Structure and Effectiveness by Sandoz International GmbH Compliance and Risk Assessment by AstraZeneca

Highlights On-stage interview with EFPIA HCP insight Special debate Expert panels Networking Interactive application Our Thank You Dasa Janosikova Conference Producer We would like to thank: our partners and sponsors for supporting us and the whole event, our speakers and advisors for contributing with their knowledge, experience and strategies, and our delegates, who were a great audience that enthusiastically proposed their ideas and boosted discussions. We were very delighted that you chose to attend the 4 th Annual Corporate Compliance & Transparency in the Pharmaceutical Industry Conference in Zürich, Switzerland and we had the chance to meet you. We believe that the event was beneficial for you in terms of both learning and networking. I hope to see many of you at the Corporate Compliance & Transparency in the Pharmaceutical Industry Conference again and look forward to hearing your new findings and experience.

How Did the Delegates Benefit? Job Title Distribution 89% 73% 91% of the attendees would recommend the event to a colleague of the attendees intend to attend next year of attendees appreciated the many networking opportunities Testimonials Very helpful insights from other companies; open and valuable best practice sharing. Nina Stoeckel, Merck KGaA Overall good speakers and content. Lenka Zemanova, Ferring 68% 27% Industry professionals Solution providers 5% Academia/Other Geographical Distribution Great networking, well done. Mia Rasmussen, UCB 70% 20% 8% 2% Other Western Europe Central & Eastern Europe Southern Europe

Participating Companies A. Menarini AbbVie Accenture Acino Pharma Allergan Amgen Europe Astellas AstraZeneca B. Braun Melsungen Baker & McKenzie Baxalta Bayer Healthcare Biogen Boehringer Ingelheim EFPIA EGA -European Generic Medicines Association Eli Lilly European Hematology Association EHA F. Hoffmann - La Roche Ferring International Center Ferring Pharmaceuticals Fresenius Medical Care GAN Integrity Solutions Genesis Pharma GlaxoSmithKline Global Risk Profile Guerbet Hemopharm Johnson & Johnson KPMG LEO Pharma Switzerland Libbs Pharmaceutial MediSpend Meetings & Events International Merck Merck Group Mylan Novartis Novo Nordisk Novo Nordisk Healthcare Polaris Polpharma Roche Sandoz Stratulat Albulescu Takeda UCB Vifor Pharma Zoetis Partners Silver Sponsors: GRP TRUE DILIGENCE Bronze Sponsor: Lunch Sponsor: Promotional Sponsor:

The Next Annual 5 th Annual Corporate Compliance & Transparency in the Pharmaceutical Industry 22-23 February 2017 Zurich, Switzerland For sponsorship opportunities: Robert Markus Senior Business Development Manager Fleming. Budapest, Hungary T: +36 1 411 1929 F: +361 411 1841 E: robert.markus@fleming.events For media partnership opportunities: Martina Hrabinska Marketing Manager Fleming. Bratislava, Slovak Republic T: +421 257 272 145 F: +421 255 644 490 E: martina.hrabinska@fleming.events ABOUT Fleming. Fleming. connects great people, useful know-how and valuable opportunities. With 12 years in the business and 300+ events organized annually, Fleming. has grown to offer a portfolio of Conferences, Trainings, Exhibitions, Blended Learning and Online Conferences. Present on five continents Fleming. has partnerships to always stay one step ahead. More than 50,000 satisfied companies participating at our events every year prove that Fleming. is the right partner. For more information, visit.